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Abstract: 
Background: Recruitment to paediatric palliative care research is 
challenging, with high rates of non-invitation of eligible families by 
clinicians. The impact on sample characteristics is unknown.  
 
Aim: To investigate, using mixed methods, non-invitation of eligible 
families and ensuing selection bias in an interview study about parents’ 
experiences of advance care planning (ACP study).  
 
Design: We examined differences between eligible families invited and not 
invited to participate by clinicians using: (i) field notes of discussions with 
clinicians during the invitation phase; (ii) anonymised information from the 
service’s clinical database.  
 
Setting: Families were eligible for the ACP study if their child was receiving 
care from a UK-based tertiary palliative care service (Group A; N=519) or 
had died 6-10 months previously having received care from the service 
(Group B; N=73).  
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Results: Rates of non-invitation to the ACP study were high. 28 (5.4%) 
Group A families and 21 (28.8%) Group B families (p<0.0005) were 
invited. Family-clinician relationship appeared to be a key factor associated 
qualitatively with invitation in both groups. In Group A, total contact with 
family (adjusted odds ratio 1.06 [95% CI 1.01 – 1.11]; p=0.027) and out-
of-hours contact with family (adjusted odds ratio 5.78 [95% CI 2.28 – 
14.67]; p<0.0005) were statistically associated with invitation. Qualitative 
findings also indicated that clinicians’ perceptions of families’ wellbeing, 
circumstances, characteristics, engagement with clinicians, and anticipated 
reaction to invitation influenced invitation.  
 
Conclusion: We found evidence of selective invitation practices that could 
bias research findings. Non-invitation and selection bias should be 
considered, assessed and reported in palliative care studies. 
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Title 
 
Inviting parents to take part in paediatric palliative care research: a mixed methods examination of 
selection bias 
 
Abstract 
 
Background: Recruitment to paediatric palliative care research is challenging, with high rates of non-
invitation of eligible families by clinicians. The impact on sample characteristics is unknown.  
 
Aim: To investigate, using mixed methods, non-invitation of eligible families and ensuing selection bias 
in an interview study about parents’ experiences of advance care planning (ACP study). 
 
Design: We examined differences between eligible families invited and not invited to participate by 
clinicians using: (i) field notes of discussions with clinicians during the invitation phase; (ii) anonymised 
information from the service’s clinical database. 
 
Setting: Families were eligible for the ACP study if their child was receiving care from a UK-based tertiary 
palliative care service (Group A; N=519) or had died 6-10 months previously having received care from 
the service (Group B; N=73).  
 
Results: Rates of non-invitation to the ACP study were high. 28 (5.4%) Group A families and 21 (28.8%) 
Group B families (p<0.0005) were invited. Family-clinician relationship appeared to be a key factor 
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associated qualitatively with invitation in both groups. In Group A, total contact with family (adjusted 
odds ratio 1.06 [95% CI 1.01 – 1.11]; p=0.027) and out-of-hours contact with family (adjusted odds ratio 
5.78 [95% CI 2.28 – 14.67]; p<0.0005) were statistically associated with invitation. Qualitative findings 
also indicated that clinicians’ perceptions of families’ wellbeing, circumstances, characteristics, 
engagement with clinicians, and anticipated reaction to invitation influenced invitation. 
 
Conclusion: We found evidence of selective invitation practices that could bias research findings. Non-
invitation and selection bias should be considered, assessed and reported in palliative care studies. 
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Key statements 
 
What is already known about the topic? 
• Recruitment is challenging in palliative care research, in part due to professional gate-keeping. 
• This may result in selection bias, which can influence the external validity of study findings. 
• Despite these potential consequences, the nature and degree of selection bias is rarely 
examined or reported. 
 
What this paper adds? 
• Identifies key factors which may give rise to low invitation rates and selection bias in paediatric 
palliative care research, and provides a model for how these factors interact. 
• Demonstrates the utility and efficacy of a mixed-method approach to investigating selection 
bias due to non-invitation. 
 
Implications for practice, theory or policy 
• Researchers should assess and report non-invitation rates and selection bias wherever possible. 
• Anonymised, routinely collected clinical data combined with qualitative study of invitation 
practices is an effective method for detecting non-random invitation to participate.  
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Introduction 
 
High-quality research is needed to inform best practice in palliative care.
1
 However, research quality and 
applicability may be limited by challenges to successful recruitment, not only due to moderate response 
rates, but also significant rates of non-invitation to participate.
2-4
  
 
Non-invitation of some patients who meet the eligibility criteria described in a study protocol is 
sometimes referred to as ‘gate-keeping’.
5
 Gate-keeping, while sometimes unavoidable, may result in 
selection bias, where invited patients differ systematically from non-invited eligible patients. The 
external validity of the findings may therefore be compromised.
6, 7
 Further, gate-keeping may reduce 
the sample size or increase the time required for recruitment.
6
  These effects can compromise the value 
and applicability of the research to policy and practice.  
While non-response bias in paediatric palliative care is beginning to be investigated,
8
 knowledge of non-
response bias is of limited use if the sampling frame itself is biased by selective invitation. Despite 
concern about this potential selection bias,
3
 the nature and degree of such bias is largely unknown.  
In this paper, we examine the selective invitation of eligible families to participate in paediatric palliative 
care research. We use as a case study example a pilot interview study about advance care planning for 
children with a life-limiting condition (the ‘ACP study’), in which the sampling frame was large, yet 
invitation rates were low. The findings from the ACP study itself will be reported elsewhere. We use 
mixed methods to: (1) explore clinicians’ practices with regard to invitation and the reasons for their 
decisions; (2) examine statistical differences between invited families and non-invited families; (3) 
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discuss the implications of our findings for palliative care research. We define ‘invitation rate’ and ‘non-
invitation rate’ as the proportion of eligible patients approached and not approached about the study, 
respectively.  
 
Background information about the ACP study 
 
The ACP study sample was drawn from the caseload of a UK tertiary referral centre for children’s 
palliative care, comprising patients with a diverse range of malignant and non-malignant conditions, 
ethnic and socioeconomic backgrounds, and ages (0-19 years). As a specialist referral service in a tertiary 
institution with an extensive  outreach program, the team of clinicians works collaboratively with 
multiple services and other institutions to support children and their families in various care 
settings(home, hospice, tertiary children’s hospital and local hospitals). The ACP study was designed 
with input from the clinicians in the palliative care service. 
 
Potential participants eligible for inclusion were parents with a living child receiving palliative care 
services from the clinical team (Group A), and bereaved parents of a child who had received care from 
the clinical team and died 6-10 months previously (Group B). Parents were ineligible if they were (i) 
participating in another research study or had completed participation within the last six months (this 
was later revised to include only psychosocial research), or (ii) unable to give informed consent. 
 
Fourteen clinicians including medical and nursing members of the palliative care service were available 
to approach eligible families between December 2011 and December 2012 to invite them to participate 
in the ACP study. This was the first time many members of the palliative care service had been asked to 
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approach families for a research study. Adhering to the processes approved by the responsible ethics 
committee, initially clinicians approached Group A families during routine contact (e.g. telephone call or 
face-to-face visit). They were asked to give families a brief verbal introduction to the ACP study and 
offer them an information pack. Parents could then contact the research team for further information. 
Due to the lack of regular contact with families beyond six months’ bereavement, clinicians were asked 
to mail information packs to bereaved families with a personal covering letter. From August 2012 (nine 
months into recruitment), clinicians could also approach Group A families via mail if they preferred. 
Invitations were registered on the clinical team’s electronic database. Invitations continued until at least 
6 families had agreed to take part in each group: the invitation period spanned December 2011 to 
December 2012 for Group A and January 2012 to June 2012 for Group B. 
 
All clinicians were trained at the start of the recruitment period via an interactive presentation led by 
the research team, who were already known to them. Following this, the research team arranged 
regular meetings with clinicians at their workplace to discuss their experiences and any concerns, 
updated clinicians on recruitment progress and thanked them for any invitations during weekly team 
meetings, displayed reminder posters in the clinical team office, and provided pocket guides to 
approaching families. The clinical data manager (AD) created an automatic pop-up message which 
appeared when clinicians opened an eligible living patient’s electronic record, and identified and printed 
a list of eligible bereaved families each month, which was displayed in the clinical team office. In 
response to low invitation rates, an ‘opt-out’ policy was promoted by the lead nurse (JH)- from three 
months into recruitment, to encourage clinicians to approach all eligible families; this was supported by 
introducing protected time during clinical team meetings to discuss approaching families identified as 
eligible. 
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Methods 
 
Data collection and analysis 
 
Two datasets were utilised to investigate differences between families invited and not invited to the 
ACP study.  
 
Dataset 1 consisted of ethnographic field notes recorded prospectively by two researchers (JC and EB) 
during the invitation period, including 88 individual conversations between researchers and clinicians, 
29 clinical team meetings and 3 research seminars (held jointly with clinical and research teams). The 
anonymised field notes included clinicians’ views on and experiences of inviting families from Groups A 
and B to take part in the ACP study.  
 
Field notes were analysed thematically: (i) A researcher (JC) coded them inductively with respect to 
factors potentially associated with invitation and non-invitation of families. (ii) The coding framework 
was discussed, revised and re-implemented by the research team (JC, EB, PK). (iii) A second researcher 
(EB) independently coded 20% of the field notes; comparison with the original coding led to further 
refinement of the framework and re-coding of the dataset. (iv) A researcher (JC) also indexed the 
dataset for references to Group A versus Group B families, blind to the previous coding. (v) Two 
researchers (JC and EB) compared Group A and B within each category of the coding framework, 
identifying similarities and differences between the two groups. All coding and indexing was carried out 
using QSR NVivo 10 software. 
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Dataset 2 consisted of anonymised, individual-level quantitative information extracted from the clinical 
team’s electronic database about the families who met the inclusion criteria for Group A (N=519) and 
Group B (N=73) during the invitation period. The data were de-identified by a member of the clinical 
team (AD) in accordance with the Information Commissioner’s Office code of practice for data 
anonymisation.
10
 
 
The variables extracted from the database are shown in Table 1. These variables were selected because 
they were routinely recorded with relatively little missing data, and were thought both from literature 
review and preliminary analysis of Dataset 1 to be possibly associated with invitation. 
 
Within each group (A and B), families invited were statistically compared with families not invited on 
each of these variables. Variables significantly associated with invitation status at the 10% level on two-
tailed univariate analysis were entered into a logistic regression model using a forward stepwise 
selection procedure (pentry = 0.10, premoval = 0.15). Continuous variables not linear in the logit of invitation 
status were transformed into categorical variables. In order to minimise the risk of re-identifying 
individuals by data combination, the individual-level data were provided by the clinical team initially in 
univariate form (i.e. each variable linked only to invitation status, and not to the other variables). Only 
variables which qualified for multi-variable analysis were then provided in multi-variable form (i.e. 
linked to each other). Variables significant at the 5% level in the logistic regression model using a two-
tailed likelihood ratio test were considered independently associated with invitation status. All analyses 
were carried out using IBM SPSS Statistics 21. 
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We used a convergent parallel mixed method design, based on a pragmatist philosophy and giving equal 
priority to qualitative and quantitative data.
11
 Dataset 1 was collected during the invitation period 
(December 2011 – December 2012), whereas Dataset 2 was extracted after recruitment had finished 
(September – December 2013). The two datasets were then analysed concurrently and independently, 
before the results were combined for interpretation.  
 
Regulatory approvals 
 
A favourable opinion for this study was received from the London Bloomsbury NHS Research Ethics 
Committee (11/LO/0710) and Great Ormond Street Hospital NHS Foundation Trust (09NS06). 
 
Results  
 
Invitation rates 
 
During the invitation period, 519 living patients and 73 deceased patients met the inclusion criteria for 
Group A and B respectively, according to the clinical team database. Of these patients, clinicians invited 
the parents of 28 (5.4%) in Group A and 21 (28.8%) in Group B (p<0.0005). Each clinician (N=14) invited 
1-31 (median 2) families. The Group A invitation rate did not increase after introduction of a mail option 
for approaching families (4.2% before vs. 2.7% after; p=0.2). 
 
Factors affecting invitation and non-invitation 
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Thematic analysis of Dataset 1 revealed three sets of factors which influenced clinicians’ decisions to 
invite or not invite families to the ACP study: (i) family factors, relating to clinicians’ perceptions of 
families and families’ worlds; (ii) family-clinician contact and relationship, relating to clinicians’ 
perceptions of their interactions with families; and (iii) clinician factors, relating to clinicians’ 
perceptions of themselves and their own worlds. These were interrelated (Figure 1). 
 
(i) Family factors 
 
In Dataset 1, several family factors were associated qualitatively with invitation and non-invitation: 
wellbeing, circumstances, characteristics, engagement with healthcare professionals and anticipated 
reaction to invitation (Table 2). In addition, on 3 occasions families were deemed ineligible to take part 
because they were participating in other research. In Dataset 2, there was no significant difference 
between families invited and not invited in terms of the patient’s age, gender, ethnic group, diagnosis or 
time since referral to the service (Tables 3 and 5), and none of these factors appeared influential in 
Dataset 1.  
 
(ii) Family-clinician contact and relationship 
Contact between the clinical team and families was a key factor associated with invitation to Group A in 
Dataset 1, even after the mail option for approaching families had been introduced. For example, one 
clinician commented that ‘although [research ethics committee] have approved inviting Group A by 
post… she would never want to send out a cold letter.’ This desire for contact before inviting parents of 
living children was sometimes associated with: (i) deferring/waiting until the next contact, which was 
not necessarily predictable; (ii) forgetting to introduce the study; (iii) coincidence with a ‘difficult 
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conversation’ (both actual and anticipated) or a period of patient instability or crisis, such that invitation 
was perceived to be ‘inappropriate’; (iv) aborting the invitation when the subject of research was 
broached, due to perceived ‘negative signals’ from the family. 
 
Consistent with these observations, there was a strong statistical association between the amount of 
family-clinician contact while families were eligible and the likelihood of invitation in Group A (Tables 3 
and 4). In Group B, none of the contact variables were statistically significantly associated with invitation 
status on univariate analysis, and none qualified for multivariable analysis(Table 5). Group B families 
were much less likely to have had contact with the palliative care team while eligible for invitation 
compared to Group A families (5.5% vs. 63.6% respectively; p<0.0005). 
 
 
Another related factor to emerge from the field notes (Dataset 1) was how the clinicians characterised 
their relationship with each family. Clinicians appeared reluctant to invite families they had a strained or 
new relationship with, preferring to invite families that they had a ‘good’ relationship with and/or knew 
well. For example one clinician ‘seemed happy to post out a couple of packs to families she felt she had 
a good relationship with.’ Another deferred inviting a family because ‘she has only met the family once 
and “needs to build a relationship” with them before introducing the study’. Accordingly, invited 
families had had more contact with the palliative care team before becoming eligible (Group A) or 
before patient death (Group B) than non-invited families (Tables 3 & 5), although in Group B this 
association did not attain statistical significance. 
 
(iii) Clinician factors 
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Clinician factors that appeared to influence invitation in Dataset 1 included: available time; 
forgetting/remembering to introduce study; shared or changing responsibility for patient care; 
comfort/discomfort with postal mode of invitation; perceived benefit of study to patient/family; and 
confidence in inviting families (Figure 1). For example, with regard to inviting parents of living children 
one clinician spoke of her fear that ‘inviting families at the wrong time could jeopardise her clinical 
relationship with them, undoing everything that has been built so far’. Clinicians’ time and confidence 
were issues in inviting bereaved families too. One clinician preferred to call bereaved families before 
posting invitations because ‘she feels she needs to talk to them rather than just inviting them to take 
part’. However this took time (‘about half an hour’) and sometimes delayed invitations. For others there 
was discomfort and hence delay when they had not been in contact with the family for some time. 
 
Discussion 
 
Our report increases understanding of the nature, effects and complexity of issues surrounding the 
recruitment of participants to research in paediatric palliative care. In our exemplar, the ACP study, the 
proportion of eligible families invited to participate was unexpectedly low, particularly among families of 
living children (Group A) compared to deceased children (Group B).  
Our findings suggest that the family-clinician relationship was a key factor influencing invitation. 
Families with whom clinicians had frequent contact, knew well and/or felt they had a ‘good’ relationship 
appeared more likely to be invited. These relationships may have seemed more robust and therefore 
less likely to be jeopardised by an invitation to take part in research. One reason for the higher invitation 
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rate in Group B could be the cessation of the therapeutic relationship following patient death, leading to 
a perception that invitation was less risky.  
Clinicians’ perception of families’ wellbeing and circumstances also appeared to play an important role; 
within this category, patient instability and proximity to death were identified as barriers to invitation 
unique to Group A, and could further explain the lower invitation rate in this group. Furthermore, family 
experience relevant to the study was identified as a facilitator to invitation; this may have led to some 
Group A families being excluded due to a perceived lack of experience of advance care planning. 
Our findings, if replicated in similar projects, have implications for the validity and applicability of 
research. In quantitative research, such differences between those invited and not invited would 
indicate an unrepresentative sample and might limit the generalisability of findings. In qualitative 
research, the implications of such differences would depend on the nature of the study and the 
observed differences. Qualitative studies often benefit from purposive or theoretical sampling of 
‘information-rich’ cases,
12
 and bias can be reduced by incorporating a wide range of different 
perspectives.
13
 In the ACP study, the clinicians’ selective invitation of families perceived to have good 
communication skills, for example, may have provided rich data at the individual participant level; 
however, the exclusion of families perceived to lack these skills may have led to an absence of diverse 
perspectives. 
Many studies in palliative care are hampered by low rates of invitation. Hinds et al.
2
 reported that in 
prospective studies about end-of-life decision making for children with cancer, up to 27% of eligible 
families were placed in a ‘do-not-approach’ category by clinicians, and a ‘missed opportunity’ rate of 
54.9% was reported. The proportion of families placed in a ‘do-not-approach’ category was also higher 
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in prospective studies where the child was still living compared to retrospective studies where the child 
was deceased.
2
 
Similar factors contributing to a reluctance of healthcare professionals to introduce research have been 
reported internationally, including concerns about impact on family- or patient-professional 
relationships,
14-19
 patient/family wellbeing or burden,
2, 3, 17-23
 family ‘type’,
21
 disease prognosis
16
 or 
proximity to death,
3
 anticipated refusal,
14, 20, 21
 time constraints,
17, 18, 20, 21, 24
 forgetting to ask,
2, 15
 and 
doubts about participant benefit.
14, 25, 26
 Other factors identified in the literature (e.g. clinicians’ research 
experience and gender
26
) could not be assessed given the characteristics of our cohort of clinicians. 
A primary strength of our paper is the use of mixed methods. By using an ethnographic prospective 
approach, we could both identify factors influencing invitation and consider how they interact. This was 
complemented by quantitative data on invitation practice using anonymised, routinely collected clinical 
data. However, we were unable to study some potentially important variables such as parent 
demographics, first language and education, as these were not available. Also lacking was information 
regarding families’ participation in other research; we could not therefore identify and exclude all 
ineligible patients. Our field notes suggest that such patients would constitute a small proportion of the 
dataset, and therefore would have had minimal impact on our analyses. Another limitation was the 
small number of invited families (particularly in Group B) so that we could detect only large differences 
between invited and non-invited families. Perhaps most importantly, without opportunities to speak to 
eligible non-invited families, we could not pursue the impact of selective invitation on the findings of the 
ACP study. 
In conclusion, our findings highlight the potential for selection bias in paediatric palliative care research. 
The nature and degree of selection bias is likely to vary across studies, according to research design and 
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local context – an issue which warrants further study. We recommend that when designing studies, 
researchers consider how the method and mode of invitation might impact on non-invitation rates and 
selection bias, and how these could be minimised. We would suggest a mixed method assessment of the 
invitation and recruitment process, including observation of practice, prospective interviews with 
clinicians and examination of anonymised data about the sampling frame. While routine clinical data are 
rarely used for this purpose, they can be a valuable resource. Finally, we encourage researchers to 
report non-invitation rates and selection bias wherever possible, to aid interpretation of research 
findings. 
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Table 1. Variables extracted from the palliative care team database. 
Variable name Description Type/format and 
response categories 
Reason for inclusion 
Family invitation status Whether or not the 
patient’s parent(s) 
were invited to 
take part 
Binary variable (‘invited’ 
or ‘not invited’) 
Outcome of interest 
Age Patient’s age at 
start of recruitment 
period (Group A) or 
death (Group B) 
Continuous variable, 
rounded to the nearest 
month if under 1 year or 
to the nearest year if 
over 1 year (to protect 
patient identity) 
Basic demographic information; 
possible confounding factor 
Gender Patient’s gender Binary variable (‘male’ or 
‘female’) 
Basic demographic information; 
possible confounding factor 
Ethnicity Patient’s ethnicity Binary variable (‘White 
British/UK’ or ‘Other’) 
Basic demographic information; 
possible confounding factor. 
Quantitative research revealed 
an association between ethnicity 
and participation in a paediatric 
palliative care study.
8
 Due to 
considerations of data quality 
and patient privacy, we were 
unable to break down ‘Other’ 
into meaningful categories. 
Diagnosis Patient’s diagnosis Binary variable 
(‘malignant’ or ‘non-
malignant’) 
Patients with malignant and non-
malignant disease are referred to 
the palliative care service via 
different routes and are managed 
differently by the service. Due to 
considerations of data quality 
and patient privacy, we were 
unable to break down these 
categories into meaningful sub-
groups. 
Time between referral 
to the service and study 
eligibility (Group A) or 
death (Group B) 
in months Continuous variable, 
rounded to the nearest 
month (to protect 
patient identity) 
Qualitative research suggests 
clinician’s knowledge of and/or 
relationship with patients 
influences invitation to clinical 
trials, paediatric and palliative 
care research.
14,17,21
 In the ACP 
study, contact during eligibility 
periods constituted a direct 
opportunity for invitation. 
Total family contact 
time with the palliative 
care service during 
eligibility period (Group 
A) 
In hours, including 
face-to-face visits 
and telephone calls 
Continuous variable 
Number of days of 
contact with the 
palliative care service 
during eligibility period 
(Group A) 
Including face-to-
face visits and 
telephone calls 
Continuous variable 
Total family contact 
time with the palliative 
care service 12 months 
before patient eligibility 
(Group A) 
In hours, including 
face-to-face visits 
and telephone calls 
Continuous variable 
Number of days of Including face-to- Continuous variable 
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contact with the 
palliative care service 12 
months before patient 
eligibility (Group A) 
face visits and 
telephone calls 
Total family OOH 
telephone contact time 
with the palliative care 
service during patient’s 
eligibility period (Group 
A) 
In hours Continuous variable 
Number of days of OOH 
telephone contact with 
the palliative care 
service during patient’s 
eligibility period (Group 
A) 
 Continuous variable 
Total family OOH 
telephone contact time 
with the palliative care 
service 12 months 
before patient eligibility 
(Group A) 
In hours Continuous variable 
Number of days of OOH 
telephone contact with 
the palliative care 
service 12 months 
before patient eligibility 
(Group A) 
 Continuous variable 
Total family contact 
time with the palliative 
care service 12 months 
before patient death 
(Group B) 
In hours, including 
face-to-face visits 
and telephone calls 
Continuous variable 
Number of days of 
contact with the 
palliative care service 12 
months before patient 
death (Group B) 
Including face-to-
face visits and 
telephone calls 
Continuous variable 
Total family OOH 
telephone contact time 
with the palliative care 
service 12 months 
before patient death 
(Group B) 
In hours Continuous variable 
Number of days of OOH 
telephone contact with 
the palliative care 
service 12 months 
before patient death 
(Group B) 
 Continuous variable 
Total family contact 
time with the palliative 
care team 0<6 months 
post-bereavement 
(Group B) 
In hours, including 
face-to-face visits 
and telephone calls 
Continuous variable 
Total family contact In hours, including Continuous variable 
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time with the palliative 
care team 6-10 months 
post-bereavement i.e. 
during eligibility period 
(Group B) 
face-to-face visits 
and telephone calls 
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Table 2. Perceived family factors associated with invitation or non-invitation in Group A and Group B 
(Dataset 1) 
 
Factor Description Excerpt from field notes 
Wellbeing and 
circumstances 
• parent’s emotional, mental 
or physical condition 
• patient stability/instability 
and proximity to death 
(Group A only) 
• extraneous family 
circumstances 
• availability and adequacy 
of psychological support 
‘She [clinician] does not want to 
approach one family because she did 
not know parent well and remembers 
they were very stressed.’ (Group B) 
 
‘She [clinician] will consider inviting 
them [parents] next week when they 
will come back to have patient’s line 
taken out. It depends on the results of 
the scan which are due before then and 
may be distressing for the parents.’ 
(Group A) 
Characteristics • persona e.g. ‘lovely’, 
‘difficult’ 
• language and 
communication skills 
• literacy 
• experience relevant to 
study 
• previously expressed 
willingness to take part in 
research/help others 
• location within/outside 
service catchment area 
‘[Clinician] says the parent would be 
great as she is “very articulate” and 
would be very good at explaining why 
she made a decision.’ (Group B) 
 
‘[Clinician] does not want to invite one 
family as they cannot read.’ (Group A) 
 
‘…[family] would be a good candidate as 
parent has been involved in a lot of 
planning…’ (Group A) 
Engagement or 
communication 
with healthcare 
professionals 
• willingness to engage with 
healthcare professionals 
• responsiveness to attempts 
to contact family 
‘…[family] have asked for palliative care 
involvement and emergency care 
planning, so [clinician] thinks they 
would be good for ACP project.’ (Group 
A) 
 
‘parent… does not want any more 
contact with [hospital] professionals.’ 
(Group B) 
Anticipated 
reaction to 
invitation 
• distressed/upset 
• annoyed 
• not interested 
‘[Clinician] says today will not be a good 
time to invite them [family] as she will 
be discussing the patient’s Emergency 
Care Plan – this is likely to be difficult for 
the family and she thinks they would 
probably just throw the information 
pack in the bin.’ (Group A) 
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Table 3. Univariate analyses of parent invitation to Group A (N=519) 
 
  Invited Not invited p- Missing 
  (N=28) (N=491) value data 
Patient’s age at start of 
recruitment period (years)
 
– 
median (IQR) 
4.5 (0.7 - 13) 4 (0.6 - 10) 0.46 0 (0.0%) 
Patient’s ethnicity 
   
 
    White British/UK 7/17 (41.2%) 125/375 (33.3%) 0.50 127 (24.5%) 
    Other 10/17 (58.8%) 250/375 (66.7%) 
 
 
Patient’s gender 
   
 
    Male 14/28 (50.0%) 245/490 (50.0%) >0.99 1 (0.2%) 
    Female 14/28 (50.0%) 245/490 (50.0%) 
 
 
Patient’s diagnosis 
   
 
    Malignant * 38/491 (7.7%) 0.48 0 (0.0%) 
    Non-malignant * 453/491 (92.3%) 
 
 
Time between referral to service 
and start of eligibility period 
(months)
a 
– median (IQR) 
2 (0 – 16) 4 (0 – 21) 0.92 0 (0.0%) 
Total family contact during 
eligibility period (hours)
a 
– 
median (IQR) 
7.5 (3.0 - 16.7) 1.0 (0.0 - 3.4) <0.0005 0 (0.0%) 
Total family contact 12 months 
before eligible (hours)
a 
– median 
(IQR) 
2.1 (0.0 - 6.6) 0.0 (0.0 - 1.5) <0.0005 0 (0.0%) 
Total OOH family contact during 
eligibility period (hours)
a 
– 
median (IQR) 
0.2 (0.0 - 0.7) 0.0 (0.0 - 0.0) <0.0005 0 (0.0%) 
Total OOH family contact 12 
months before eligible (hours)
a 
– 
median (IQR) 
0.0 (0.0 - 0.2) 0.0 (0.0 - 0.0) 0.001 0 (0.0%) 
IQR, interquartile range. 
OOH, out-of-hours. Out-of-hours contact with the OOPC service is initiated by parents during 
weekday nights (6pm – 8am) and weekends. In this dataset it constituted 4.5% and 4.3% of the total 
contact between families and the OOPC service during eligibility period and 12 months prior, 
respectively. 
* Due to there being fewer than 5 patients per cell in the malignant group, these numbers have been 
suppressed to preserve patient anonymity.  
a
 The number of days of contact and out-of-hours contact during eligibility and 12 months prior were 
also included in the univariate analyses, but due to their strong correlation with the equivalent total 
contact time variables (Spearman’s r > 0.96; p<0.001), these variables were excluded from the 
multivariable analysis in favour of the more precise contact time. 
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Table 4. Multivariable analysis of parent invitation to Group A (N=519). Nagelkerke R square = 0.19. 
 
Variable in model 
Crude odds ratio 
(95% CI) 
Adjusted odds ratio 
(95% CI) 
p-value 
Total family contact during 
eligibility period (hours) 
1.11 (1.06 - 1.17) 1.06 (1.01 - 1.11) 0.027 
Some OOH contact during 
eligibility period (yes/no) 
9.45 (4.25 - 21.04) 5.78 (2.28 - 14.67) <0.0005 
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Table 5. Univariate analyses of parent invitation to Group B (N=73) 
 
  Invited Not invited p-value Missing 
  (N=21) (N=52) 
 
data 
Patient’s age at death (years)
 
– 
median (IQR) 
5 (0.8 – 11) 3 (0.8 - 11) 0.80 0 (0.0%) 
Patient’s ethnicity     
    White British/UK 7/15 (46.7%) 18/42 (42.9%) 0.80 16 (21.9%) 
    Other 8/15 (53.3%) 24/42 (57.1%)   
Patient’s gender     
    Male 11/21 (52.4%) 34/52 (65.4%) 0.30 0 (0.0%) 
    Female 10/21 (47.6%) 18/52 (34.6%)   
Patient’s diagnosis     
    Malignant 6/21 (28.6%) 19/52 (36.5%) 0.52 0 (0.0%) 
    Non-malignant 15/21 (71.4%) 33/52 (63.5%)   
Time between referral to service 
and patient death (months)
a
 – 
median (IQR) 
1 (0.5 - 9.5) 5 (1 - 12.5) 0.27 0 (0.0%) 
Total family contact during 
eligibility period (6-10 months post 
death) (hours) – median (IQR) 
0.0 (0.0 - 0.0) 0.0 (0.0 - 0.0) 0.83 0 (0.0%) 
Total family contact 0<6 months 
post death (hours) – median (IQR) 
0.2 (0.0 - 0.7) 0.0 (0.0 - 1.5) 0.99 0 (0.0%) 
Total family contact 12 months 
before death (hours) – median 
(IQR) 
5.7 (2.4 - 18.9) 3.9 (1.3 - 12.7) 0.13 0 (0.0%) 
Total OOH family contact 12 
months before death (hours) – 
median (IQR) 
0.0 (0.0 - 1.5) 0.0 (0.0 - 0.6) 0.39 0 (0.0%) 
IQR, interquartile range 
OOH, out-of-hours. Out-of-hours contact with the OOPC service is initiated by parents during 
weekday nights (6pm – 8am) and weekends. In this dataset it constituted 8.9% of the total contact 
between families and the OOPC service 12 months prior to patient death. 
Page 29 of 29
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
Figure 1. Factors influencing invitation and non-invitation of families by clinicians. 
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